Summary
“Hologic to Acquire Gen-Probe for $3.7 Billion - A Move to Create a Leading Diagnostics Franchise Focused on Womens Health” provides key insights on the deal. The report provides an analysis on the inorganic growth strategies of Hologic, Gen-Probe’s product innovations and pipeline, Hologics’s financial performance and opportunities in the molecular diagnostics market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry.
- Qualitative analysis on Hologic’s acquisition of Gen-Probe.
- The Market penetration of Hologic in the molecular diagnostics market.
- Company profiles of Hologic, Inc. and Gen-Probe Incorporated.
Reasons to buy
- Understand the business strategy behind this deal by a medical device company to strengthen its current product portfolio and enter new product segments showing positive future growth trend.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the global regenerative medicine market
“Hologic to Acquire Gen-Probe for $3.7 Billion - A Move to Create a Leading Diagnostics Franchise Focused on Womens Health” provides key insights on the deal. The report provides an analysis on the inorganic growth strategies of Hologic, Gen-Probe’s product innovations and pipeline, Hologics’s financial performance and opportunities in the molecular diagnostics market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry.
- Qualitative analysis on Hologic’s acquisition of Gen-Probe.
- The Market penetration of Hologic in the molecular diagnostics market.
- Company profiles of Hologic, Inc. and Gen-Probe Incorporated.
Reasons to buy
- Understand the business strategy behind this deal by a medical device company to strengthen its current product portfolio and enter new product segments showing positive future growth trend.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the global regenerative medicine market
1.1 List of Tables 1
1.2 List of Figures 1
2 Hologic to Acquire Gen-Probe For $3.7 Billion - A Move to Create a Leading Diagnostics Franchise Focused on Womens Health 1
2.1 Deal Summary 1
2.2 Deal Impact on Industry 2
2.3 Deal Rationale 2
2.4 Company Profiles 8
2.5 Analyst Commentary 9
3 Appendix 9
3.1 Research Methodology 10
3.2 Secondary Research 10
3.3 Primary Research 10
3.4 Models 10
3.5 Forecasts 11
3.6 Expert Panels 11
3.7 GlobalData Consulting 11
3.8 Contact Us 11
3.9 Disclaimer 11" "
1.2 List of Figures 1
2 Hologic to Acquire Gen-Probe For $3.7 Billion - A Move to Create a Leading Diagnostics Franchise Focused on Womens Health 1
2.1 Deal Summary 1
2.2 Deal Impact on Industry 2
2.3 Deal Rationale 2
2.4 Company Profiles 8
2.5 Analyst Commentary 9
3 Appendix 9
3.1 Research Methodology 10
3.2 Secondary Research 10
3.3 Primary Research 10
3.4 Models 10
3.5 Forecasts 11
3.6 Expert Panels 11
3.7 GlobalData Consulting 11
3.8 Contact Us 11
3.9 Disclaimer 11" "
1.1 List of Tables
Table 1: Key Deals Among Medical Device Manufacturers and Molecular Diagnostics Companies, 2010-2012 2
Table 2: Gen-Probe, Product Portfolio, Global, 2012 5
Table 3: Hologic, Inc., Acquisitions, 2007-2012 6
Table 4: Hologic, Inc., Company Snapshot 8
Table 5: Hologic, Inc., Business Segments Overview 8
Table 6: Gen-Probe Incorporated, Company Snapshot 9" "
Table 1: Key Deals Among Medical Device Manufacturers and Molecular Diagnostics Companies, 2010-2012 2
Table 2: Gen-Probe, Product Portfolio, Global, 2012 5
Table 3: Hologic, Inc., Acquisitions, 2007-2012 6
Table 4: Hologic, Inc., Company Snapshot 8
Table 5: Hologic, Inc., Business Segments Overview 8
Table 6: Gen-Probe Incorporated, Company Snapshot 9" "
1.2 List of Figures
Figure 1: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio 3
Figure 2: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio 4
Figure 3: Pipeline Products of Gen-Probe, 2012 7
Figure 1: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio 3
Figure 2: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio 4
Figure 3: Pipeline Products of Gen-Probe, 2012 7
For more information, please visit:
Or email us at press@aarkstore.com or call +919272852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No: +919272852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://blogs.aarkstore.com/
Follow us on twitter: http://twitter.com/aarkstoredotcom
No comments:
Post a Comment